Human FGF20/FGF-20/RHDA2 ORF/cDNA clone-Lentivirus particle (NM_019851)
Cat. No.: vGMLP001865
Pre-made Human FGF20/FGF-20/RHDA2 Lentiviral expression plasmid for FGF20 lentivirus packaging, FGF20 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
FGF20/FGF-20 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP001865 | Human FGF20 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP001865 |
| Gene Name | FGF20 |
| Accession Number | NM_019851 |
| Gene ID | 26281 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 636 bp |
| Gene Alias | FGF-20,RHDA2 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCTCCCTTAGCCGAAGTCGGGGGCTTTCTGGGCGGCCTGGAGGGCTTGGGCCAGCAGGTGGGTTCGCATTTCCTGTTGCCTCCTGCCGGGGAGCGGCCGCCGCTGCTGGGCGAGCGCAGGAGCGCGGCGGAGCGGAGCGCGCGCGGCGGGCCGGGGGCTGCGCAGCTGGCGCACCTGCACGGCATCCTGCGCCGCCGGCAGCTCTATTGCCGCACCGGCTTCCACCTGCAGATCCTGCCCGACGGCAGCGTGCAGGGCACCCGGCAGGACCACAGCCTCTTCGGTATCTTGGAATTCATCAGTGTGGCAGTGGGACTGGTCAGTATTAGAGGTGTGGACAGTGGTCTCTATCTTGGAATGAATGACAAAGGAGAACTCTATGGATCAGAGAAACTTACTTCCGAATGCATCTTTAGGGAGCAGTTTGAAGAGAACTGGTATAACACCTATTCATCTAACATATATAAACATGGAGACACTGGCCGCAGGTATTTTGTGGCACTTAACAAAGACGGAACTCCAAGAGATGGCGCCAGGTCCAAGAGGCATCAGAAATTTACACATTTCTTACCTAGACCAGTGGATCCAGAAAGAGTTCCAGAATTGTACAAGGACCTACTGATGTACACTTGA |
| ORF Protein Sequence | MAPLAEVGGFLGGLEGLGQQVGSHFLLPPAGERPPLLGERRSAAERSARGGPGAAQLAHLHGILRRRQLYCRTGFHLQILPDGSVQGTRQDHSLFGILEFISVAVGLVSIRGVDSGLYLGMNDKGELYGSEKLTSECIFREQFEENWYNTYSSNIYKHGDTGRRYFVALNKDGTPRDGARSKRHQKFTHFLPRPVDPERVPELYKDLLMYT |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-SE0919-Ab | Anti-FGF20/ FGF-20/ RHDA2 functional antibody |
| Target Antigen | GM-Tg-g-SE0919-Ag | FGF20 protein |
| Cytokine | cks-Tg-g-GM-SE0919 | fibroblast growth factor 20 (FGF20) protein & antibody |
| ORF Viral Vector | pGMLP001865 | Human FGF20 Lentivirus plasmid |
| ORF Viral Vector | vGMLP001865 | Human FGF20 Lentivirus particle |
Target information
| Target ID | GM-SE0919 |
| Target Name | FGF20 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
26281 |
| Gene ID |
100050037 (Equus caballus), 100855820 (Canis lupus familiaris), 101083766 (Felis catus), 26281 (Homo sapiens) 539083 (Bos taurus), 66017 (Rattus norvegicus), 701847 (Macaca mulatta), 80857 (Mus musculus) |
| Gene Symbols & Synonyms | FGF20,Fgf20,RHDA2,FGF-20,FGF4A,Fgf4a |
| Target Alternative Names | FGF-20,FGF20,FGF4A,Fgf20,Fgf4a,Fibroblast growth factor 20,RHDA2 |
| Uniprot Accession |
Q9ESL9,Q9EST9,Q9NP95
Additional SwissProt Accessions: Q9NP95,Q9EST9,Q9ESL9 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Cytokine Target |
| Disease | |
| Disease from KEGG | MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Chemical carcinogenesis - receptor activation, Melanoma, Breast cancer, Gastric cancer |
| Gene Ensembl | ENSECAG00000035169, ENSCAFG00845014402, ENSG00000078579, ENSBTAG00000044043, ENSMMUG00000062368, ENSMUSG00000031603 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


